// App-Quantinova.ai

P341 : Combination of corticosteroids and 5-aminosalycilates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: a global survey of physicians' practice

Researchers

Presenter

  • S. Ben-Horin

Principal Investigators

  • J.M. Andrews

  • K.H. Katsanos

  • F. Rieder

  • F. Steinwurz

  • K. Karmiris

  • J.H. Cheon

  • G.W. Moran

  • M. Cesarini

  • C.D. Stone

  • D. Schwartz

  • M. Protic

  • X. Roblin

  • G. Roda

  • M. Chen

  • O. Har-Noy

  • C.N. Bernstein

Medical Centers

  • Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

  • Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia

  • University Hospital of Ioannina, Ioannina, Greece

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Hospital Israelita Albert Einstein, Sao Paulo, Brazil

  • Venizeleion General Hospital, Heraklion, Heraklion, Greece

  • Yonsei University College of Medicine, Seoul, Korea

  • Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom

  • Sapienza University of Rome, ROMA, Italy

  • Comprehensive Digestive Institute of Nevada, Las Vegas, Nevada, United States

  • Soroka University Medical Center, Beer Sheva, Israel

  • University Hospital Zemun, Belgrade, Serbia

  • University Hospital of Saint-Etienne, Saint-Etienne, France

  • S.Orsola Malpighi Hospital, Bologna, Italy

Locations

  • Israel

  • China

  • Australia

  • Greece

  • United States

  • Brazil

  • Republic of South Korea

  • United Kingdom

  • Italy

  • Serbia

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved